Celldex Therapeutics (CLDX) Asset Utilization Ratio (2011 - 2026)

Celldex Therapeutics' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.0 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 83.96% year-over-year to 0.0; the TTM figure through Mar 2026 stood at 0.0 (down 83.96% YoY), while the FY2025 annual figure was 0.0, down 79.87% from the prior year.
• Asset Utilization Ratio was 0.0 for Q1 2026 at Celldex Therapeutics, down from 0.0 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.02 in Q4 2023 to a low of 0.0 in Q1 2026.
• Historically, Asset Utilization Ratio has averaged 0.01 across 5 years, with a median of 0.01 in 2024.
• The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio sank 95.1% in 2022, then surged 439.49% in 2023.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2022, then soared by 182.66% to 0.02 in 2023, then sank by 52.91% to 0.01 in 2024, then slumped by 71.11% to 0.0 in 2025, then plunged by 36.96% to 0.0 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.0 (Q1 2026), 0.0 (Q4 2025), and 0.0 (Q3 2025), per Business Quant data.